CBIO

•

Equity

GLOBAL X CHINA BIOTECH UCITS ETF

TER (bps):

68

AUM (USD m):

1

ISIN:

IE0004LIBFM2

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

China

As of:

16 Apr 2024

Climate Fund:

No

Benchmark

The Solactive China Biotech v2 Index measures performance of companies involved in the development of biotechnology in China, including companies whose principal business is in research, development, manufacturing, and distribution of new drugs, therapies, or vaccines using biological materials.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo

RELATED ARTICLES

Statue of bull after the Shenzen Exchange in China
Industry Updates

China and precious metal ETFs disappoint in Q2

The big re-opening has underwhelmed

Theo Andrew

Nuclear power station
New Listing

Global X launches uranium ETF

Tracking around 50 companies in the uranium industry

Theo Andrew

MOST READ

1
New Listing

ARK Invest Europe launches innovation, genomics and AI ETFs

Theo Andrew

2
Industry Updates

BlackRock world ETF flash crashes on Deutsche Boerse as liquidity vanishes

Theo Andrew

3
Analysis

Which sectors and factors outperform in wartime?

Nicolas Rabener

4
Interview

ARK Invest Europe: ‘10 ETFs is plenty’

Tom Eckett

5
New Listing

BlackRock expands fixed-maturity range with US Treasury and Italian BTP ETFs

Tom Eckett